Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Plakoglobin Reduces the in vitro Growth, Migration and Invasion of Ovarian Cancer Cells Expressing N-Cadherin and Mutant p53.

Alaee M, Danesh G, Pasdar M.

PLoS One. 2016 May 4;11(5):e0154323. doi: 10.1371/journal.pone.0154323. eCollection 2016.

2.

Role of N-cadherin in proliferation, migration, and invasion of germ cell tumours.

Bremmer F, Schallenberg S, Jarry H, Küffer S, Kaulfuss S, Burfeind P, Strauß A, Thelen P, Radzun HJ, Ströbel P, Honecker F, Behnes CL.

Oncotarget. 2015 Oct 20;6(32):33426-37. doi: 10.18632/oncotarget.5288.

3.

Wnt/β-catenin pathway as a potential prognostic and predictive marker in patients with advanced ovarian cancer.

Bodnar L, Stanczak A, Cierniak S, Smoter M, Cichowicz M, Kozlowski W, Szczylik C, Wieczorek M, Lamparska-Przybysz M.

J Ovarian Res. 2014 Feb 6;7:16. doi: 10.1186/1757-2215-7-16.

4.

N-cadherin expression in malignant germ cell tumours of the testis.

Bremmer F, Hemmerlein B, Strauss A, Burfeind P, Thelen P, Radzun HJ, Behnes CL.

BMC Clin Pathol. 2012 Oct 15;12:19. doi: 10.1186/1472-6890-12-19.

5.

E-cadherin's dark side: possible role in tumor progression.

Rodriguez FJ, Lewis-Tuffin LJ, Anastasiadis PZ.

Biochim Biophys Acta. 2012 Aug;1826(1):23-31. doi: 10.1016/j.bbcan.2012.03.002. Epub 2012 Mar 13. Review.

6.

N-cadherin in neuroblastoma disease: expression and clinical significance.

Lammens T, Swerts K, Derycke L, De Craemer A, De Brouwer S, De Preter K, Van Roy N, Vandesompele J, Speleman F, Philippé J, Benoit Y, Beiske K, Bracke M, Laureys G.

PLoS One. 2012;7(2):e31206. doi: 10.1371/journal.pone.0031206. Epub 2012 Feb 15.

7.

Toward an integrative analysis of the tumor microenvironment in ovarian epithelial carcinoma.

Serio RN.

Cancer Microenviron. 2012 Aug;5(2):173-83. doi: 10.1007/s12307-011-0092-5. Epub 2011 Nov 23.

8.

Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity.

Strauss R, Li ZY, Liu Y, Beyer I, Persson J, Sova P, Möller T, Pesonen S, Hemminki A, Hamerlik P, Drescher C, Urban N, Bartek J, Lieber A.

PLoS One. 2011 Jan 14;6(1):e16186. doi: 10.1371/journal.pone.0016186. Erratum in: PLoS One. 2011;6(2). doi: 10.1371/annotation/8c637352-3614-406c-89dc-e78d10fa069c.

9.

The clinical behavior of mixed ductal/lobular carcinoma of the breast: a clinicopathologic analysis.

Suryadevara A, Paruchuri LP, Banisaeed N, Dunnington G, Rao KA.

World J Surg Oncol. 2010 Jun 21;8:51. doi: 10.1186/1477-7819-8-51.

10.

Trypsin-induced proteome alteration during cell subculture in mammalian cells.

Huang HL, Hsing HW, Lai TC, Chen YW, Lee TR, Chan HT, Lyu PC, Wu CL, Lu YC, Lin ST, Lin CW, Lai CH, Chang HT, Chou HC, Chan HL.

J Biomed Sci. 2010 May 11;17:36. doi: 10.1186/1423-0127-17-36.

11.

Abnormal placental development and early embryonic lethality in EpCAM-null mice.

Nagao K, Zhu J, Heneghan MB, Hanson JC, Morasso MI, Tessarollo L, Mackem S, Udey MC.

PLoS One. 2009 Dec 31;4(12):e8543. doi: 10.1371/journal.pone.0008543.

12.

Lipocalin2 expressions correlate significantly with tumor differentiation in epithelial ovarian cancer.

Cho H, Kim JH.

J Histochem Cytochem. 2009 May;57(5):513-21. doi: 10.1369/jhc.2009.953257. Epub 2009 Feb 2.

13.

Smad7 induces hepatic metastasis in colorectal cancer.

Halder SK, Rachakonda G, Deane NG, Datta PK.

Br J Cancer. 2008 Sep 16;99(6):957-65. doi: 10.1038/sj.bjc.6604562.

15.

The role of activin A and Akt/GSK signaling in ovarian tumor biology.

Do TV, Kubba LA, Antenos M, Rademaker AW, Sturgis CD, Woodruff TK.

Endocrinology. 2008 Aug;149(8):3809-16. doi: 10.1210/en.2007-1584. Epub 2008 May 1.

16.

Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression.

Hudson LG, Zeineldin R, Stack MS.

Clin Exp Metastasis. 2008;25(6):643-55. doi: 10.1007/s10585-008-9171-5. Epub 2008 Apr 9. Review.

17.
18.

Sequential molecular and cellular events during neoplastic progression: a mouse syngeneic ovarian cancer model.

Roberts PC, Mottillo EP, Baxa AC, Heng HH, Doyon-Reale N, Gregoire L, Lancaster WD, Rabah R, Schmelz EM.

Neoplasia. 2005 Oct;7(10):944-56.

19.

E-cadherin and cytokeratin subtype profiling in effusion cytology.

Han J, Kim MK, Nam SJ, Yang JH.

J Korean Med Sci. 2004 Dec;19(6):826-33.

20.

Neural-cadherin expression associated with angiogenesis in non-small-cell lung cancer patients.

Nakashima T, Huang C, Liu D, Kameyama K, Masuya D, Kobayashi S, Kinoshita M, Yokomise H.

Br J Cancer. 2003 Jun 2;88(11):1727-33.

Supplemental Content

Support Center